Research groups
DPhil Opportunities
We will be accepting DPhil student applications to start in October 2021 soon.
Katherine Vallis
Professor of Experimental Radiotherapeutics
- Group Leader, Oxford Institute for Radiation Oncology
- Honorary Consultant in Clinical Oncology, Oxford University Hospitals NHS Trust
Research Summary
Our research focus is on understanding and exploiting the biological effects of external beam ionizing radiation and therapeutic radionuclides in solid tumours (breast, lung, pancreas, oesophageal and colorectal cancers among others).
Biography
Katherine undertook specialist training in Clinical Oncology at the Hammersmith Hospital and doctoral research at Edinburgh University. In 1995 she was appointed as Staff Radiation Oncologist at the Princess Margaret Hospital and Scientist at the Ontario Cancer Institute, Toronto. She returned to the UK in 2006 to join the Oxford Institute for Radiation Oncology and established the Experimental Radiotherapeutics Group.
GROUP MEMBERS
Sarah Able, Laboratory Manager
Ole Tietz, Postdoctoral Researcher
Fernando Cortezon-Tamarit, Postdoctoral Researcher
Joao Lourenco, DPhil Student
Anis Theljani, Postdoctoral Researcher
Rachel Anderson, DPhil Student
Abirami Lakshminarayanan, Postdoctoral Researcher
Sreejesh Sreedharan, Postdoctoral Researcher
Recent publications
-
9th International Symposium on Physical, Molecular, Cellular, and Medical Aspects of Auger Processes: Preface.
Journal article
Vallis KA. et al, (2022), Int J Radiat Biol, 1 - 2
-
Impact of Cyclic Changes in Pharmacokinetics and Absorbed Dose in Pediatric Neuroblastoma Patients Receiving [177Lu]Lu-DOTATATE
Journal article
VALLIS K. et al, (2022), EJNMMI Physics
-
Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells
Journal article
VALLIS K., (2022), Nature Chemistry
-
Engineering Enzyme-Cleavable Oligonucleotides by Automated Solid-Phase Incorporation of Cathepsin B Sensitive Dipeptide Linkers.
Journal article
Brown T. et al, (2021), Angew Chem Int Ed Engl
-
3-Bromopyruvate-Mediated MCT1-Dependent Metabolic Perturbation Sensitizes Triple Negative Breast Cancer Cells to Ionizing Radiation
Journal article
VALLIS K. et al, (2021), Cancer and Metabolism